Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles
Agnes T. Reiner(Austrian Institute of Technology), Sai Kiang Lim(Io Therapeutics (United States)), Joel de Beer(Ernst Basler + Partner (Switzerland)), Milad Riazifar(University of California, Irvine), Ilona Reischl(Federal Chancellery Republic of Austria), Eva Rohde(Medical University of Graz), Hang Yin(Cornell University), Yijun Yang(Synageva BioPharma (United States)), Randolph Corteling(ReNeuron (United Kingdom)), Bernd Giebel(University of Duisburg-Essen), Wei Seong Toh(National University of Singapore), Vicky K. Yang(Tufts University), Charles Pin‐Kuang Lai(Harvard University), Marca H. M. Wauben(University of Applied Sciences Utrecht), Susanne Gabrielsson(Karolinska University Hospital), Mario Gimona(Austrian Academy of Sciences), Hernando A. del Portillo(Institució Catalana de Recerca i Estudis Avançats), Bas W. M. van Balkom(University Medical Center Utrecht), Dominique P.V. de Kleijn(Utrecht University), Carlos Salomón(The University of Queensland), Chaya Brodie(Bar-Ilan University), Hidetoshi Tahara(Hiroshima University), Kenneth W. Witwer(Johns Hopkins University), Jan Lötvall(University of Gothenburg), Ronne Wee Yeh Yeo(Institute of Medical Biology), Ahmed Ibrahim(Capricor Therapeutics (United States))
Cited by 359
Related Papers
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
|Journal of Extracellular Vesicles|2018|11.4k
Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
|The Journal of Immunology|2007|1.2k
Defining mesenchymal stromal cell (MSC)‐derived small extracellular vesicles for therapeutic applications
|Journal of Extracellular Vesicles|2019|652
Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters
|Nature Communications|2015|592
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
|Brain Behavior and Immunity|2009|574